相关实验视频

Updated: Jan 13, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

使用认知障碍查测试验证认知功能测试的有效性

Hyuk Sung Kwon¹, Jeewon Suh², Geun U Park³

¹Department of Neurology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.

Journal of clinical neurology (Seoul, Korea)

|January 10, 2026

概括

认知障碍查测试 (CIST) 与之前的查测试 (PST) 相比,在检测早期认知障碍方面显示出更高的准确性. 这个验证支持CIST.

科学领域:

神经学神经学
老年学是指老年学的学科.
公共卫生公共卫生

背景情况:

早期发现认知障碍对于及时干预至关重要.
认知障碍查测试 (CIST) 是为早期认知障碍检测而开发的.
CIST的临床实用性需要在现实环境中进行验证.

研究的目的:

为了比较CIST的诊断性能与之前的查测试 (PST).
在现实世界的大规模环境中验证CIST的临床实用性.

主要方法:

从ANSYS数据库 (2017-2023) 中分析了7,492,613个人的查数据.
根据年龄,性别和教育分层的CIST和PST分数的比较.
使用接收器运行特征 (ROC) 曲线对差异性性能进行评估.
在CIST和PST之间进行得分转换的Equipercentile等值方法.

主要成果:

在CIST中,认知障碍者比例比PST (10.72%) 高 (12.68%).
与PST (AUC=0.776) 相比,CIST显示出更高的预测准确度 (AUC=0.790).
已确立的分数转换:CIST 20=PST 24,CIST 15=PST 20,CIST 5=PST 10. 这里可以看到分数转换.

结论:

认知障碍查测试 (CIST) 是用于查认知障碍的有效和有效工具.
与之前的查测试 (PST) 相比,CIST的预测准确度更高.
由于潜在的差异,建议在CIST和PST之间直接转换得分时谨慎使用.

关键词:

在 ANSYS 数据库中,您可以使用 ANSYS 数据库.认知障碍查测试是认知障碍的查测试.痴呆症痴呆症是一种痴呆症.卫生保健政策医疗保健政策

更多相关视频

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

相关概念视频

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.